|
|
British Journal of Cancer (2002) 86, 239-243.
doi:10.1038/sj/bjc/6600018
Screening for oesophageal neoplasia in patients with head and neck cancer
H Scherübl1, B von Lampe1, S Faiss1, P Däubler1, P Bohlmann2, T Plath3, H-D Foss4, H Scherer2, A Strunz3, B Hoffmeister3, H Stein4, M Zeitz1 and E-O Riecken1
1Medical Clinic I, University Hospital Benjamin Franklin, Free University of Berlin, Hindenburgdamm 30, 12200 Berlin, Germany
2ENT Department, University Hospital Benjamin Franklin, Free University of Berlin, Hindenburgdamm 30, 12200 Berlin, Germany
3Department of Maxillofacial Plastic Surgery, University Hospital Benjamin Franklin, Free University of Berlin, Hindenburgdamm 30, 12200 Berlin, Germany
4Institute of Pathology, University Hospital Benjamin Franklin, Free University of Berlin, Hindenburgdamm 30, 12200 Berlin, Germany
Correspondence to: H Scherübl, E-mail: hscher@zedat.fu-berlin.de
Received 30 May 2001; revised 2 October 2001; accepted 15 October 2001
Due to advanced disease at the time of diagnosis the prognosis of oesophageal cancer is generally poor. As mass screening for oesophageal cancer is neither feasible nor reasonable, high-risk groups should be identified and surveilled. The aim of this study was to define the risk of oesophageal cancer in patients with (previous) head and neck cancer. A total of 148 patients with (previous) head and neck cancer were prospectively screened for oesophageal cancer by video-oesophagoscopy and random oesophageal biopsies. Even in a macroscopically normal looking oesophagus, four biopsy specimens were taken every 3 cm throughout the entire length of the squamous oesophagus. Low- or high-grade squamous cell dysplasia was detected histologically in 10 of the 148 patients (6.8%). All but one dysplasias were diagnosed synchronously with the head and neck cancers. In addition, oesophageal squamous cell carcinoma was diagnosed in 11 of the 148 patients (7.4%). Most invasive cancers (63.6%) occurred metachronously. The risk of squamous cell neoplasia of the oesophagus is high in patients with (previous) head and neck cancer. Surveillance is recommended in this high-risk group.
Keywords: surveillance; secondary malignancy; squamous cell cancer; larynx; pharynx; oral cavity
back to top  |
| Article links | |
| ||
| ||
 | Send to a friend | |
 | Download PDF | |
| ||
| ||
| ||
 | Full text | |
| ||
| ||
| ||
 | Preceding article | |
 | Next article | |
 | Table of Contents | |
| ||
| ||
| ||
| ||
| ||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2002 Cancer Research UK | ||
| |||
| Privacy Policy | |||